UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

American Cancer Society prostate cancer survivorship care guidelines

CA: a cancer journal for clinicians, 2014-07, Vol.64 (4), p.225-249

2014

Volltextzugriff (PDF)

Life under the CABOSUN: Cabozantinib improves quality‐adjusted survival in comparison with sunitinib

Cancer, 2020-12, Vol.126 (24), p.5210-5212

2020

Volltextzugriff (PDF)

Role of chemotherapy in prostate cancer

Asian journal of andrology, 2018-05, Vol.20 (3), p.221-229

2018

Volltextzugriff (PDF)

ARASENS: making sense out of first-line metastatic hormone-sensitive prostate cancer treatment

Asian journal of andrology, 2023-01, Vol.25 (1), p.1-4

Aragon-Ching, Jeanny

2023

Volltextzugriff (PDF)

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

Journal of clinical oncology, 2023-07, Vol.41 (19), p.3486-3492

2023

Volltextzugriff (PDF)

The Utility of Chemotherapy in the Treatment of Metastatic Prostate Cancer

Anti-cancer agents in medicinal chemistry, 2016-09, Vol.16 (9), p.1166-1171

2016

Volltextzugriff (PDF)

Vitamin D in prostate cancer

Asian journal of andrology, 2018-05, Vol.20 (3), p.244-252

2018

Volltextzugriff (PDF)

Final analysis of a phase II trial using sorafenib for metastatic castration‐resistant prostate cancer

BJU international, 2009-06, Vol.103 (12), p.1636-1640

2009

Volltextzugriff (PDF)

The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer

Asian journal of andrology, 2021-01, Vol.23 (1), p.1-2

Aragon-Ching, Jeanny B

2021

Volltextzugriff (PDF)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer

Asian journal of andrology, 2020-01, Vol.22 (1), p.76-78

Aragon-Ching, Jeanny

2020

Volltextzugriff (PDF)

The changing landscape in the treatment of metastatic castration-resistant prostate cancer

Therapeutic Advances in Medical Oncology, 2013-01, Vol.5 (1), p.25-40

2013

Volltextzugriff (PDF)

Multidisciplinary treatment (MDT) perspectives in renal cell carcinoma

Therapeutic advances in urology, 2023-01, Vol.15, p.17562872231182216-17562872231182216

2023

Volltextzugriff (PDF)

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights. Oncology, 2019, Vol.13, p.1179554919833927-1179554919833927

2019

Volltextzugriff (PDF)

Role of immunotherapy in bladder cancer

Cancer treatment and research communications, 2021, Vol.26, p.100296-100296, Article 100296

2021

Volltextzugriff (PDF)

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer

Clinical Medicine Insights. Oncology, 2021, Vol.15, p.117955492110449-11795549211044963

2021

Volltextzugriff (PDF)

Editorial: Radical cystectomy in bladder cancer patients

Frontiers in oncology, 2022-12, Vol.12, p.1113112-1113112

2022

Volltextzugriff (PDF)

Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas

Urologic oncology, 2017-07, Vol.35 (7), p.462-464

Aragon-Ching, Jeanny B., M.D., F.A.C.P

2017

Volltextzugriff (PDF)

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

Clinical cancer research, 2008-07, Vol.14 (13), p.4200-4205

2008

Volltextzugriff (PDF)

The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)

Exploration of targeted anti-tumor therapy, 2024-01, Vol.5 (4), p.971-980

2024

Volltextzugriff (PDF)

Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data

Clinical genitourinary cancer, 2019-12, Vol.17 (6), p.436-442

2019

Volltextzugriff (PDF)

The role of switch maintenance therapy in urothelial cancers

Therapeutic Advances in Urology, 2023-01, Vol.15, p.17562872221147760-17562872221147760

2023

Volltextzugriff (PDF)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights. Oncology, 2016-03, Vol.2016 (Suppl. 1), p.11-19

2016

Volltextzugriff (PDF)

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for immunotherapy of cancer, 2022-08, Vol.10 (8), p.e005147

2022

Volltextzugriff (PDF)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights. Oncology, 2016-01, Vol.2016 (Suppl. 1), p.57-66

2016

Volltextzugriff (PDF)

The evolution of prostate cancer therapy: targeting the androgen receptor

Frontiers in oncology, 2014-01, Vol.4, p.295-295

Aragon-Ching, Jeanny B

2014

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(111)
Life Sciences & Biomedicine
(110)
Humans
(84)
Oncology
(65)
Male
(59)
Prostate Cancer
(51)
Urology & Nephrology
(35)
Metastasis
(31)
Prostatic Neoplasms - Drug Therapy
(28)
Chemotherapy
(26)
Immunotherapy
(24)
Antineoplastic Agents - Therapeutic Use
(20)
Middle Aged
(18)
Aged
(16)
Andrology
(16)
Clinical Trials
(16)
Endocrinology & Metabolism
(16)
Review
(16)
Bladder Cancer
(15)
Tumors
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

American Cancer Society prostate cancer survivorship care guidelines

Life under the CABOSUN: Cabozantinib improves quality‐adjusted survival in comparison with sunitinib

Role of chemotherapy in prostate cancer

ARASENS: making sense out of first-line metastatic hormone-sensitive prostate cancer treatment

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

The Utility of Chemotherapy in the Treatment of Metastatic Prostate Cancer

Vitamin D in prostate cancer

Final analysis of a phase II trial using sorafenib for metastatic castration‐resistant prostate cancer

The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer

The changing landscape in the treatment of metastatic castration-resistant prostate cancer

Multidisciplinary treatment (MDT) perspectives in renal cell carcinoma

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer

Role of immunotherapy in bladder cancer

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer

Editorial: Radical cystectomy in bladder cancer patients

Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)

Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data

The role of switch maintenance therapy in urothelial cancers

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

The evolution of prostate cancer therapy: targeting the androgen receptor

Suchergebnisse filtern